Re: Chemotherapy-related myelosuppression as a marker for survival in epithelial ovarian cancer patients by Rocconi et al.

被引：1
|
作者：
Petru, Edgar [1 ]
机构：
[1] Med Univ Graz, Dept Obstet & Gynecol, A-8036 Graz, Austria
来源：
GYNECOLOGIC ONCOLOGY | 2008年 / 111卷 / 01期
关键词：
D O I：
10.1016/j.ygyno.2008.06.005
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：159 / 160
页数：2
相关论文
共 50 条
  • [1] Re: Chemotherapy-related myelosuppression as a marker for survival in epithelial ovarian cancer patients
    Rocconi, Rodney P.
    GYNECOLOGIC ONCOLOGY, 2008, 111 (01) : 160 - 160
  • [2] Chemotherapy-related myelosuppression as a marker of survival in epithelial ovarian cancer patients
    Rocconi, Rodney P.
    Matthews, Kellie S.
    Kemper, Meredith K.
    Hoskins, Kelly E.
    Barnes, Mack N.
    GYNECOLOGIC ONCOLOGY, 2008, 108 (02) : 336 - 341
  • [3] Hidden threats: Chemotherapy-related clonal hematopoiesis in patients with ovarian cancer
    Corvigno, Sara
    Asare, Amma
    Yao, Jun
    Zhao, Li
    Fleming, Nicole
    Celestino, Joseph
    Hajek, Richard
    Goette, Ency Arboleda
    Rogers, Ridge
    Lu, Karen
    Jazaeri, Amir
    Westin, Shannon
    Sood, Anil
    Lee, Sanghoon
    GYNECOLOGIC ONCOLOGY, 2024, 190 : S15 - S16
  • [4] In Regard to Ding et al. 2020: "Managing Cancer and Living Meaningfully (CALM) Intervention on Chemotherapy-Related Cognitive Impairment in Breast Cancer Survivors"
    Zarrella, Giuliana V.
    Braun, Sarah E.
    INTEGRATIVE CANCER THERAPIES, 2023, 22
  • [5] Body composition as a predictor of chemotherapy-related toxicity in ovarian cancer patients: A systematic review
    Rizzo, Stefania
    Raia, Giorgio
    Del Grande, Maria
    Gasparri, Maria Luisa
    Colombo, Ilaria
    Manganaro, Lucia
    Papadia, Andrea
    Del Grande, Filippo
    FRONTIERS IN ONCOLOGY, 2022, 12
  • [6] The association of chemotherapy induced thrombocytopenia with survival in epithelial ovarian cancer patients
    Rocconi, R. P.
    Matthews, K. S.
    Hoskins, K.
    Kemper, M.
    Finan, M.
    Barnes, M. N., III
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
  • [7] Letter re: Ban et al., A personalized probabilistic approach to ovarian cancer diagnostics
    Levine, Beverly J.
    GYNECOLOGIC ONCOLOGY, 2024, 183 : 141 - 142
  • [8] Flynn et al.: does the interval from primary surgery to chemotherapy influence progression-free survival in ovarian cancer?
    Omura, GA
    GYNECOLOGIC ONCOLOGY, 2003, 90 (02) : 498 - 498
  • [9] Rural residence is related to shorter survival in epithelial ovarian cancer patients
    Lutgendorf, Susan K.
    Ramirez, Edgardo
    Schrepf, Andrew
    Valentine, Mark C.
    Charlton, Mary
    Zimmerman, M. Bridget
    Goodheart, Michael J.
    Zia, Sharaf
    Sood, Anil K.
    Thaker, Premal H.
    GYNECOLOGIC ONCOLOGY, 2021, 163 (01) : 22 - 28
  • [10] Delay in chemotherapy administration impacts survival in elderly patients with epithelial ovarian cancer
    Joseph, Naima
    Clark, Rachel M.
    Dizon, Don S.
    Lee, Malinda S.
    Goodman, Annekathryn
    Boruta, David, Jr.
    Schorge, John O.
    del Carmen, Marcela G.
    Growdon, Whitfield B.
    GYNECOLOGIC ONCOLOGY, 2015, 137 (03) : 401 - 405
12345